Robert Huebner was one of the panelists for the Forum’s discussion on The Next Pandemic.
Robert Huebner is the Director of the Influenza Division in the Biomedical Advancement Research and Development Authority (BARDA) in the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). He has been a member of the Influenza Division since May of 2006. He was named Deputy Director of the Influenza Division in March 2009, became the Acting Director in July 2011 and was appointed Director in February 2013. He was part of the ASPR Medical Countermeasures Team that won the 2012 HHS Secretary’s Award for Distinguished Service
Dr. Huebner is an experienced biotechnology program manager with over 25 years of research experience with viral and microbiological pathogens, expertise in the vaccine industry, group management, and program management. He received his Ph.D. in Molecular Biology and Microbiology from Tufts University (Boston, MA) and his B.S. in Biology from Carnegie Mellon University (Pittsburgh, PA).
Prior to working at BARDA, Dr. Huebner worked for over ten years at Sanofi Pasteur (Swiftwater, PA) as a Manager of Molecular Biology & Microbiology where he supported vaccine development projects in the areas of Lyme disease, influenza and pneumococcal disease. Additionally, Dr. Huebner worked as a Senior Advisor and section manager for Biotechnology at the Midwest Research Institute (Kansas City, MO) for five years where he led the Biotechnology team in supporting government and commercial contract research projects in the areas of vaccine evaluation, pathogen detection and pathogen destruction.
